Literature DB >> 24351652

Serum 1,25-dihydroxyvitamin d and the development of kidney dysfunction in a Japanese community.

Kensuke Izumaru1, Toshiharu Ninomiya, Masaharu Nagata, Tomoko Usui, Daigo Yoshida, Koji Yonemoto, Masayo Fukuhara, Kazuhiko Tsuruya, Takanari Kitazono, Yutaka Kiyohara.   

Abstract

BACKGROUND: Recent evidence indicates that vitamin D deficiency is associated with an increased risk of renal impairment, but studies addressing the influence of vitamin D deficiency on the development of chronic kidney disease (CKD) in the general Asian population have been few. METHODS AND
RESULTS: A total of 2,417 community-dwelling individuals without CKD stage 3-5 aged ≥40 years were followed for 5 years (mean age, 60 years; women, 59.1%). The cumulative incidence of CKD stage 3-5, defined as estimated glomerular filtration rate (eGFR) <60ml·min(-1)·1.73m(-2), and the rate of decline in eGFR according to quartile of serum 1,25-dihydroxyvitamin D (1,25(OH)2D), were estimated. During follow-up, 378 subjects experienced CKD stage 3-5. The age- and sex-adjusted incidence of CKD stage 3-5 increased significantly with decreasing serum 1,25(OH)2D (P for trend <0.001). Compared with the highest quartile, the multivariate-adjusted odds ratio for the development of CKD stage 3-5 was 1.90 in the lowest quartile and 1.74 in the second lowest quartile, after adjusting for confounding factors. Additionally, lower serum 1,25(OH)2D was significantly associated with a greater change in eGFR (-0.10ml·min(-1)·1.73m(-2)·year(-1) per 10-pg/ml decrement in serum 1,25(OH)2D).
CONCLUSIONS: Lower serum 1,25(OH)2D is a significant risk factor for the development of CKD stage 3-5 in the general Asian population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24351652     DOI: 10.1253/circj.cj-13-0422

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.

Authors:  Eugene P Rhee; Clary B Clish; Julia Wenger; Jason Roy; Sammy Elmariah; Kerry A Pierce; Kevin Bullock; Amanda H Anderson; Robert E Gerszten; Harold I Feldman
Journal:  Am J Nephrol       Date:  2016-05-13       Impact factor: 3.754

2.  Vitamin D Level is Associated with Increased Left Ventricular Mass and Arterial Stiffness in Older Patients with Impaired Renal Function.

Authors:  Jing Chang; Xiao-Guang Ye; Yuan-Ping Hou; Jin-Ling Wu; Sheng-Li Li; Qian-Mei Sun
Journal:  Med Sci Monit       Date:  2015-12-22

3.  A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.

Authors:  Paweena Susantitaphong; Siriwan Nakwan; Sadudee Peerapornratana; Khajohn Tiranathanagul; Pisut Katavetin; Nattachai Srisawat; Kearkiat Praditpornsilpa; Somchai Eiam-Ong
Journal:  BMC Nephrol       Date:  2017-01-14       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.